GLPwatch
Constipation
17,902 FAERS reports across 13 drugs
Last updated 2026-08-26 06:04 UTCConstipation is when a person has infrequent bowel movements, hard or dry stools, or difficulty passing stool.
Plain-language definition of the term.
FDA labels for Byetta, Mounjaro, Ozempic, Rybelsus, Saxenda, Soliqua, Trulicity, Victoza, Wegovy, Xultophy, and Zepbound list constipation as an adverse reaction.
AI summary of the sources below.
FAERS report counts (as of 2026Q2) reflect voluntary adverse-event reports and cannot establish causation or true frequency; higher counts often track prescription volume. openFDA FAERS ↗
Reports by drug
| Drug | FAERS reports | Quarter |
|---|---|---|
| Ozempic | 4,406 | 2026Q2 |
| Mounjaro | 3,501 | 2026Q2 |
| Zepbound | 2,899 | 2026Q2 |
| Trulicity | 2,292 | 2026Q2 |
| Victoza | 1,279 | 2026Q2 |
| Byetta | 1,181 | 2026Q2 |
| Wegovy | 1,011 | 2026Q2 |
| Bydureon | 522 | 2026Q2 |
| Rybelsus | 420 | 2026Q2 |
| Saxenda | 334 | 2026Q2 |
| Soliqua | 31 | 2026Q2 |
| Xultophy | 25 | 2026Q2 |
| Adlyxin | 1 | 2026Q2 |